Celltrion (068270 KS): Competition Makes US Approval of New Oncology Biosimilar Unappealing
Celltrion got FDA approval for its oncology biosimilar Vegzelma. However, increasing competition and price erosion in the US market, lessen...
Biocon Ltd (BIOS IN): Stake Sale in Subsidiary Is a Step in Right Direction
Biocon divested 5.4% stake in Syngene for INR12.2B to partly fund Viatris acquisition. Stake sell in Biocon Biologics and final decision on Viatris...
ECM Weekly (12th Sep 2022) - Onewo, CALB, YSB, Medanta, Beneunder, JMDC, SH Holdings, Indigo
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
NIFTY100 Index Rebalance Preview: Couple of Changes in August, Then 5 More in September
There are two index changes at the close on 5 August, then there should be 5 more at the close on 29 September. Passive funds will have over 4-5...
Smartkarma Originals